Filing Details
- Accession Number:
- 0001171843-18-008474
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-18 17:00:18
- Reporting Period:
- 2018-12-14
- Accepted Time:
- 2018-12-18 17:00:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 3116 | Akorn Inc | AKRX | Pharmaceutical Preparations (2834) | 720717400 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1234712 | Joseph Bonaccorsi | 1925 West Field Court Suite 300 Lake Forest IL 60045 | Evp Gen Counsel & Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-12-14 | 25,000 | $4.48 | 541,283 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Reflects the weighted average purchase price of the shares purchased. The shares were purchased in multiple trades at prices ranging from $4.45 to $4.50 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares purchased at separate prices within the foregoing range.
- Following the reported transaction, the amount of shares beneficially owned includes 90,239 unvested RSUs and 451,044 shares owned outright.
Billionaire Hedge Funds
